Botanical species · safety record

Drosera rotundifolia

The EFSA Compendium of Botanicals holds 7 constituent measurements for Drosera rotundifolia. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Drosera rotundifolia L.

7Constituent measurements
0Safety records
3Cited sources
65Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 65 licensed products naming Drosera rotundifolia as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Fresh whole plants collected at the start of flowering
  • Herb(s)
  • Parties aériennes fraîches récoltées au moment de la floraison
  • Plante entière
  • Plante entière début de floraison
  • Underground part(s)
  • Whole plant
  • Whole plant (extract)

What the records describe

Constituents measured

  • Naphthoquinones5
  • Plumbagin2

Plant parts

  • Aerial part of plants6
  • Live plants1

Preparations

  • Solvent extraction4
  • Drying (dehydration)3

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
NaphthoquinonesAerial part of plantsDrying (dehydration)≥ 0.153 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
NaphthoquinonesLive plantsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
NaphthoquinonesAerial part of plantsSolvent extraction≤ 2.3 PercentGC-MSResolve DOI
NaphthoquinonesAerial part of plantsSolvent extraction≥ 1 PercentGC-MSResolve DOI
NaphthoquinonesAerial part of plantsDrying (dehydration)≤ 0.184 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
PlumbaginAerial part of plantsSolvent extraction22.3 Microgram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
PlumbaginAerial part of plantsDrying (dehydration)High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Baranyai, B., Backer, C., Reich, C., Lindequist, U. The production of 7-methyljuglone, plumbagin and quercetin in wild and cultivated Drosera rotundifolia and Drosera intermedia . Mires and peat, 2016, vol. 18. DOI
  2. Babula, Petr., Mikelova, Radka., Adam, Vojtech., Kizek, Rene., Havel, Ladislav., Sladky, Zdenek. Using of liquid chromatography coupled with diode array detector for determination of naphthoquinones in plants and for investigation of influence of pH of cultivation medium on content of plumbagin in Dionaea muscipula . Journal of chromatography b-analytical technologies in the biomedical and life sciences, 2006, vol. 842, no. 1, p. 28-35. DOI
  3. Kamarainen, T., Uusitalo, J., Jalonen, J., Laine, K., Hohtola, A. Regional and habitat differences in 7-methyljuglone content of Finnish Drosera rotundifolia . Phytochemistry, 2003, vol. 63, no. 3, p. 309-314. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue